More than a new name: Updates in the management of Clostridioides difficile infection

被引:0
|
作者
Wrynn, Alexander F. [1 ]
机构
[1] Allegheny Hlth Network, Pittsburgh, PA 15222 USA
来源
NURSE PRACTITIONER | 2024年 / 49卷 / 08期
关键词
C; diff; C. diff diagnosis; C. diff treatment; diarrhea; fidaxomicin; vancomycin; HEALTH-CARE EPIDEMIOLOGY; DISEASES SOCIETY; AMERICA IDSA; GUIDELINES;
D O I
10.1097/01.NPR.0000000000000209
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Infections from Clostridioides difficile (often called C. diff) have long presented challenges for both patients and clinicians. Traditionally, C. diff has been considered a nosocomial infection, but in recent years, a noticeable spike in community-acquired cases has occurred. C. diff infection (CDI) testing is often complicated, as various testing options with differing sensitivity and specificity for active infection are available. Also, recent guideline changes have altered the recommended treatment of infection. This article discusses recent changes to both the diagnosis and management of CDI and how they can be applied to everyday NP practice.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 50 条
  • [41] Clostridioides difficile Infection in Hospitalized Patients-A Retrospective Epidemiological Study
    Fonseca, Frederico
    Forrester, Mario
    Advinha, Ana Margarida
    Coutinho, Adriana
    Landeira, Nuno
    Pereira, Maria
    HEALTHCARE, 2024, 12 (01)
  • [42] Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection
    Carlson, Travis J.
    Gonzales-Luna, Anne J.
    Garey, Kevin W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 43 (01) : 28 - 38
  • [43] Comparison of three current Clostridioides difficile infection guidelines: IDSA/SHEA, ESCMID, and ACG guidelines
    Thabit, Abrar K.
    Alsolami, Mawadah H.
    Baghlaf, Nojoud A.
    Alsharekh, Raghad M.
    Almazmumi, Hadeel A.
    Alselami, Afrah S.
    Alsubhi, Fatmah A.
    INFECTION, 2019, 47 (06) : 899 - 909
  • [44] Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection
    Castaneda-Mogollon, Daniel
    Doolan, Cody P.
    Toppings, Noah B.
    Amarasekara, Ranmalee
    Tran, Thuy-Ann
    Pillai, Dylan R.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (07) : 774 - 785
  • [45] Beyond Antibiotics: Novel Approaches in the Treatment of Recurrent Clostridioides difficile Infection
    Zaidi, Syed Murtaza Haider
    Haider, Ramsha
    Kazmi, Syeda Amna Batool
    Husnain, Ali
    Khan, Saniah
    Merchant, Sabrina
    Tayyab, Hamnah
    Wazeen, Fazl Rahim
    Chaudhary, Ammad Javaid
    ACG CASE REPORTS JOURNAL, 2024, 11 (08)
  • [46] Trends in Medicare Spending and Utilization of Oral Medications for Clostridioides difficile Infection From 2013 to 2021
    Ying, Xiaohan
    Gogokhia, Lasha
    Jesudian, Arun b.
    Zhang, Lillian
    Crawford, Carl v
    GASTRO HEP ADVANCES, 2024, 3 (02): : 210 - 211
  • [47] Clostridioides difficile Infection: Updates on Epidemiologic Patterns, Diagnostic Tools, and Treatment Modalities
    Madkour, Lamiaa Abd El-Fattah
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2023, 12
  • [48] Clostridioides difficile Infection
    Guh, Alice Y.
    Kutty, Preeta K.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (07) : ITC49 - ITC63
  • [49] Current updates in management of Clostridium difficile infection in cancer patients
    Aziz, Muhammad
    Fatima, Rawish
    Douglass, Lindsey N.
    Abughanimeh, Omar
    Raza, Shahzad
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (03) : 473 - 478
  • [50] Ridinilazole for the treatment of Clostridioides difficile infection
    Carlson, Travis J.
    Endres, Bradley T.
    Basseres, Eugenie
    Gonzales-Luna, Anne J.
    Garey, Kevin W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (04) : 303 - 310